Skip to content

Erector Spinae Plane Block and Quadratus Lumborum Block for Total Laparoscopic Hysterectomy Compared to Total Intravenous Anesthesia: A Prospective Randomized Controlled Trial

Erector Spinae Plane Block and Quadratus Lumborum Block for Total Laparoscopic Hysterectomy Compared to Total Intravenous Anesthesia: A Prospective Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048165
Enrollment
Unknown
Registered
2021-07-04
Start date
2021-07-12
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Laparoscopic Hysterectomy

Interventions

Experimental group1:Patients receive total intravenous anesthesia
Experimental group2:patients receive erector spinae plane block
Experimental group3:Patients receive quadratus lumborum block

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective total laparoscopic hysterectomy; 2. Aged 18 to 65 years; 3. ASA Class i–ii.

Exclusion criteria

Exclusion criteria: 1. BMI >35kg/?; 2. Those who are allergic to drugs; 3. Patients with abnormal coagulation function; 4. Infection near the puncture; 5. Patients with nervous system and sperm disorders; 6. Severe heart, lung, liver and kidney system insufficiency; 7. Patients with communication barriers or other reasons not applicable to this study were excluded; 8. Those who have a history of chronic pain or who have recently taken analgesic drugs.

Design outcomes

Primary

MeasureTime frame
sufentanil consumption in the first postoperative 12h;

Secondary

MeasureTime frame
Pain score of incisional, visceral, shoulder and perineum during the first postoperative 24h;sufentanil consumption during the first postoperative 24h;first time of pressing the PCA pump;pain score of postoperative 3rd and 6th month;duration of anesthesia;duration of surgery;recovery time;first postoperative ambulation time;first postoperative exhaust time;postoperative hospital-stay time;intraoperative sufentanil consumption;intraoperative propofol consumption;intraoperative remifentanil consumption;incidence of adverse event;

Countries

China

Contacts

Public ContactWu Yun

The Second Affiliated Hospital of Anhui Medical University

wuyunanyi@163.com+86 13865958254

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026